213 related articles for article (PubMed ID: 10730738)
1. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
[TBL] [Abstract][Full Text] [Related]
2. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
3. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
[TBL] [Abstract][Full Text] [Related]
5. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
[TBL] [Abstract][Full Text] [Related]
6. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass.
Liu H; Fleming NW; Moore PG
J Clin Anesth; 2002 Sep; 14(6):452-5. PubMed ID: 12393116
[TBL] [Abstract][Full Text] [Related]
8. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
Schneider T; Heuer B; Deller A; Boesken WH
Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
[TBL] [Abstract][Full Text] [Related]
9. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
10. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
11. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
Lindemann W; Richter S; Schilling MK
Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.
Davis Z; Anderson R; Short D; Garber D; Valgiusti A
Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226
[TBL] [Abstract][Full Text] [Related]
13. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
[TBL] [Abstract][Full Text] [Related]
14. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
[TBL] [Abstract][Full Text] [Related]
15. Bleeding after intermittent or continuous r-hirudin during CVVH.
Kern H; Ziemer S; Kox WJ
Intensive Care Med; 1999 Nov; 25(11):1311-4. PubMed ID: 10654220
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation with hirudin for repeat cardiac surgery in a patient with heparin induced thrombocytopaenia].
Herman K; Vaszily M; Szentgyörgyi L; Ajzner E; Muszbek L; Péterffy A
Magy Seb; 2008; 61 Suppl():67-70. PubMed ID: 18504242
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of hirudin therapy with the Thrombelastograph.
Pivalizza EG
J Clin Anesth; 2002 Sep; 14(6):456-8. PubMed ID: 12393117
[TBL] [Abstract][Full Text] [Related]
18. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
19. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]